Skip to main content
Equibles

RTW INVESTMENTS, LP

Position in CADL — Candel Therapeutics, Inc.

CIK 1493215 NEW YORK, NY
Back to CADL Full portfolio

Position in CADL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$66,146,785
+$34,678,897 QoQ
Shares Held
6,422,018
0.0% QoQ
Ownership
8.39%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#2
of 138 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CADL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RTW INVESTMENTS, LP holds $9,530,420,260 across 63 Biotechnology names. CADL ranks #31 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MDGL
Madrigal Pharmaceuticals, Inc.
 1,993,687 $1,070,510,234
2 ARGX
Argenx SE
 709,446 $658,202,715
3 PTCT
Ptc Therapeutics, Inc.
 7,746,415 $631,875,071
4 PTGX
Protagonist Therapeutics, Inc
 5,061,175 $620,398,831
5 CGON
CG Oncology, Inc.
 8,514,590 $604,961,619
6 INSM
INSMED Inc
 4,842,880 $516,347,865
7 TNGX
Tango Therapeutics, Inc.
 13,900,620 $434,533,381
8 SYRE
Spyre Therapeutics, Inc.
 4,251,996 $377,492,204

All Filings in CADL

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $66,146,785 6,422,018
2026-03-31 $31,467,888 6,422,018